United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$220Mraised across 2 rounds since 2022, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Norwest Venture PartnersLead
Nextech InvestLead
Atlas Venture
Invus
Digitalis Ventures
Access Industries
Sanofi Ventures
T1D Fund
BB BiotechReported by Firms' own news pages
Source recordedSEC filing: $42M sold, first sale Oct 2022
From Matchpoint Therapeutics's own website and the SEC filings it signed: 2 on the team.
On the board, as filediBruce BoothDaniel BeckerJason Hafler
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Matchpoint Therapeutics's investors include Atlas Venture, Digitalis Ventures, Norwest Venture Partners, Nextech Invest and Vertex Ventures, and 8 more on record. Norwest Venture Partners led its latest round.
Matchpoint Therapeutics has raised $220M across 2 rounds since 2022.
Matchpoint Therapeutics's most recent round was a Series B of $150M in Oct 2026, led by Norwest Venture Partners.
Its most recent round, $150M in Oct 2026, is also its largest on record.
Matchpoint Therapeutics's first round on record, in Oct 2022, was backed by Atlas Venture, Vertex Ventures and Alexandria Venture Investments and 2 others.
Matchpoint Therapeutics's latest named round is a Series B, in Oct 2026.
Matchpoint Therapeutics is based in the United States.
Norwest Venture Partners led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
